Project Grant R01CA301423
Award Date 7/1/26
Completion Date 6/30/31
Dollars Obligated $670K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute awarded a $141,195 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to The University of Texas MD Anderson Cancer Center on May 15, 2026, with completion expected by April 30, 2028. This award supports a Pathway to Independence (K99/R00) career development research project investigating how tumor suppressor gene (TSG) deficiencies modulate pancreatic ductal adenocarcinoma (PDAC) response to oncogenic KRAS...
- Federal Grant Award Summary The National Cancer Institute awarded The University of Texas MD Anderson Cancer Center a $420,400 Project Grant under the Cancer Treatment Research program (CFDA 93.395) effective August 1, 2025, through July 31, 2027. This award supports exploratory studies investigating cellular resistance mechanisms to second-generation MTA-cooperative PRMT5 inhibitors (MTA:PRMT5I) in MTAP-loss tumors. The research addresses a critical clinical challenge whereby 40-60% of patients...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $421,685 project grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), awarded August 1, 2025, with a completion date of July 31, 2027. This award supports research investigating the LIFR-LCN2 pathway as a novel mechanism of immune suppression in hepatocellular carcinoma (HCC). The research aims to elucidate how loss of LIFR upregulates LCN2, leading to...
- Federal Grant Award Summary The National Cancer Institute awarded a $150,404 Project Grant to The University of Texas MD Anderson Cancer Center, effective December 1, 2025, through May 31, 2028, under the Cancer Research Manpower program (CFDA 93.398). This award supports a research project titled "Dissecting the Role of Gut Microbiome Dysbiosis in Lung Cancer Development and Progression," which investigates the mechanistic relationship between gut microbiome composition and lung...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded $688,073 to The University of Texas MD Anderson Cancer Center on June 1, 2026, under the Cancer Biology Research program (CFDA 93.396) to support a five-year project through May 31, 2031. Under the direction of Principal Investigator Dr. Peter Van Loo, this project will develop novel computational approaches to reconstruct the evolutionary history of cancer metastases. The research leverages DNA sequencing and molecular...
- Federal Grant Award Summary The University of Texas MD Anderson Cancer Center received a $163,500 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) on July 2, 2025, with completion scheduled for June 30, 2027. This award supports research aimed at developing targeted therapeutic approaches for E-cadherin-negative diffuse-type gastric adenocarcinoma (DGAC), an aggressive cancer subtype with increasing incidence rates and poor...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $131,933 project grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) effective May 1, 2026, through April 30, 2028. The award supports research training and biomedical workforce development in cancer research aligned with the National Cancer Program's strategic priorities. This project grant provides funding for institutional training infrastructure...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $616,715 to The University of Texas MD Anderson Cancer Center, with an award date of August 11, 2025 and completion date of July 31, 2030. This award supports research under the Cancer Treatment Research program (CFDA 93.395), which develops and evaluates improved methods of cancer treatment through fundamental and applied laboratory and clinical research. The funded research centers on the...
- Federal Grant Award Summary The National Cancer Institute awarded a $388,546 Project Grant under the Cancer Biology Research program (CFDA 93.396) to the University of Texas Health Science Center at Houston, effective June 1, 2026 through May 31, 2031. This five-year research project investigates the Golgi secretory pathway in chromosome 3q-amplified non-small cell lung cancer (NSCLC), with the goal of developing targeted therapeutic approaches for NSCLC cases lacking actionable mutations in...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The University of Texas MD Anderson Cancer Center a $621,632 project grant effective June 17, 2026, through May 31, 2031, under the Cancer Treatment Research program (CFDA 93.395). This award funds research to elucidate the molecular and metabolic mechanisms underlying disulfidptosis, a previously unexplored form of regulated cell death induced by disulfide stress in SLC7A11-high cancer cells. The research...